|
Market Closed -
NYSE
01:30:00 27/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 40.95 USD | +0.10% |
|
-0.02% | +56.36% |
Main features
| US46435U1925 | Fees | 0.47% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (INR) | 2.29TCr | Replication Method | Direct (Physical) |
| Number of securities | 52 | AuM evolution | - | Date of creation | 11/06/2019 |
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
CBOE
| IDNA | Real-time | |
NYSE
| IDNA | Delayed |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | - |
| Theme and Sector | BioTech & Genomics |
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/26/26 | $40.95 | +0.10% | 60,190 |
| 23/26/23 | $40.91 | -0.32% | 76,002 |
| 22/26/22 | $41.04 | -3.89% | 3,04,430 |
| 21/26/21 | $42.70 | +0.28% | 1,42,234 |
| 20/26/20 | $42.58 | +3.96% | 1,22,905 |
- Stock Market
- ETF
- IDNA ETF
Select your edition
All financial news and data tailored to specific country editions





















